Rybojad M, Moraillon I, Laglenne S, Vignon-Pennamen M D, Bonvalet D, Prigent F, Saada V, Merle F, Crouzet F, Cambiaghi S, Morel P
Hôpital Saint-Louis, Paris.
Ann Dermatol Venereol. 1998 Oct;125(10):679-81.
Lichen planus is in children uncommon and poorly understood. The classical description is comparable to lichen planus in adults. We conducted a retrospective analysis of 12 cases in children.
Twelve children with lichen planus consulted the Saint-Louis or Robert-Debré hospitals between February 1994 and March 1996. Data collected included: age, sex, ethnic origin, drug use, anti-hepatitis vaccination status, disease history, physical examination, skin histology, liver tests, hepatitis B and C serology, treatment and outcome. Histological proof was obtained in all cases but one (a child with isolated ungueal involvement whose sister had histologically proven ungueal lichen planus).
The clinical features classically described in adults were atypical in all our childhood cases. A rapidly extensive eruption was the main sign in 6 cases. The localizations were unusual with lesions involving all four limbs and the trunk as well as the face in 5 cases and the scalp in 1. Mucosal involvement, observed in 65 p. 100 of adult cases was only found in one of our children. Unguel involvement also appears to be uncommon in children. The etiological pattern was also unusual since we did not observe a single case related to drugs or hepatitis B or C infection. Three children developed a lichen eruption after anti-hepatitis B infection. Four other cases of lichen planus after anti-hepatitis B vaccination have been reported in the literature. Mean delay between the booster vaccination and onset of eruption is reported to be 40 days. The increased incidence of childhood lichen planus in tropical zones suggests ethnic, genetic and climatic factors may be involved. Prognosis is poorly defined in the literature. Certain authors emphasize the long duration of the disease and resistance to treatment in cases of childhood lichen planus. Currently, there is no consensus on treatment. Dermocorticoids in combination with antihistaminics are usually prescribed. General corticosteroid therapy would appear to be warranted in extensive progressive forms with important functional and esthetic impact (scalp involvement with cicatricial alopecia, pigmentation sequellae). The role of other drugs, particularly retinoids, remains to be defined. This retrospective series was not statistically significant. Data in the literature are rather discordant, emphasizing the need for a prospective analysis to acquire a better understanding of the real incidence of childhood lichen planus and better define the therapeutic strategy.
扁平苔藓在儿童中并不常见,人们对此了解甚少。其经典描述与成人扁平苔藓相似。我们对12例儿童扁平苔藓病例进行了回顾性分析。
1994年2月至1996年3月期间,12名患扁平苔藓的儿童到圣路易医院或罗贝尔·德布雷医院就诊。收集的数据包括:年龄、性别、种族、用药情况、抗肝炎疫苗接种状况、病史、体格检查、皮肤组织学、肝功能检查、乙肝和丙肝血清学、治疗及预后。除1例(1名仅有甲部受累的儿童,其姐姐经组织学证实患有甲部扁平苔藓)外,所有病例均获得了组织学证据。
在我们所有儿童病例中,成人经典描述的临床特征均不典型。6例的主要体征为皮疹迅速广泛发作。皮疹分布异常,5例累及四肢、躯干及面部,1例累及头皮。成人病例中65%出现黏膜受累,而我们的儿童病例中仅1例出现。甲部受累在儿童中似乎也不常见。病因模式也不寻常,因为我们未观察到1例与药物或乙肝、丙肝感染相关的病例。3名儿童在感染乙肝后出现扁平苔藓样皮疹。文献中还报道了另外4例乙肝疫苗接种后发生扁平苔藓的病例。据报道,加强免疫接种与皮疹发作之间的平均间隔时间为40天。热带地区儿童扁平苔藓发病率增加表明可能涉及种族、遗传和气候因素。文献中对预后的定义不明确。某些作者强调儿童扁平苔藓病程长且对治疗有抵抗性。目前,对于治疗尚无共识。通常开具皮质类固醇与抗组胺药联合使用。对于广泛进展型且有重要功能和美观影响(头皮受累伴瘢痕性脱发、色素沉着后遗症)的病例,全身使用皮质类固醇似乎是必要的。其他药物,特别是维甲酸类药物的作用仍有待确定。这个回顾性系列研究无统计学意义。文献中的数据相当不一致,这强调需要进行前瞻性分析,以更好地了解儿童扁平苔藓的实际发病率,并更好地确定治疗策略。